Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Drug Breakthrough in Fight Against Neglected Diseases

Published: Thursday, April 01, 2010
Last Updated: Thursday, April 01, 2010
Bookmark and Share
Scientists have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.

Scientists from the Drug Discovery Unit (DDU) at the University of Dundee - working together with partners at the University of York and the Structural Genomics Consortium in Toronto - have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.

Their findings, published in the latest edition of the scientific journal Nature, describe a new approach to tackling the fatal parasitic disease human African trypanosomiasis (HAT), commonly known as sleeping sickness due to disturbance of the sleep cycle caused by parasites infecting the brain.

The breakthrough made at Dundee shows promise for the development of effective, orally administered, low toxicity drugs to treat sleeping sickness.

“This is one of the most significant findings made in recent years in terms of drug discovery and development for neglected diseases,” said Professor Paul Wyatt, Director of the Drug Discovery for Tropical Diseases programme at Dundee.

“We now have a valid drug target for HAT and have found leads for drugs which can be dosed orally. These two findings represent significant strides in the development of a full blown drug against sleeping sickness suitable for clinical trials.

“HAT comes in two stages - we know the drug leads we have identified in this paper can treat the first stage and we are very optimistic that we can now further develop them to treat the second, more serious stage.”

It is estimated that drugs may be ready for human clinical trials in around 18 months.

Dr. Shing Chang, R&D Director of the Drugs for Neglected Diseases Initiative, said, “This is a significant discovery. It is a good example of applying state of the art scientific knowledge and tools in a collaborative effort to address the unmet needs of neglected patients.”

In response to the need for new and safe treatments, the DDU has already made good progress in developing compounds that have proved effective at killing the parasites, and that work well in the first stage of the disease.  The compounds disrupt the enzyme N-myristoyl transferase, or NMT for short, which is essential for survival and growth of the parasites.

“The process of developing drugs consists of a number of hurdles which have to be passed,” said Professor Wyatt. “The first is identifying an Achilles heel of the parasite, such as an enzyme which is essential for the survival of the parasites, known as a drug target.

“The second is to confirm that molecules can disrupt these targets and so kill the parasite, a process called “target validation”. The next is “lead optimization” to develop these early molecules into candidate drugs for clinical trials. That is where we are now. The final hurdle is to show safety and efficacy of the new drug in patients.”

The Dundee team worked with partners from the University of York and the Structural Genomics Consortium during the course of the research.

Professor Debbie Smith’s group in York’s Centre for Immunology and Infection (CII) originally identified NMT as a drug target with great promise for HAT.  Together with colleagues in the York Structural Biology Lab, Professor Smith and her team also developed the assay and materials for screening in Dundee.

Professor Smith said, “We are excited that our research has contributed to development of a novel compound that kills parasites, an important step in developing new therapeutics against this neglected tropical disease.  Our early proof-of-principle studies together with recent definitive experiments confirming the specificity of the new compounds confirm the importance of working collaboratively in the quest for new drugs in this area”.

Dr Ray Hui’s group within the SGC produced a three-dimensional representation of how the new molecules interact with NMT. This information greatly aids the design of better compounds and can accelerate the discovery of new drug candidates.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Potential New Diagnosis and Therapy for Breast Cancer
Scientists at the University of York, using clinical specimens from charity Breast Cancer Now’s Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.
Monday, October 12, 2015
All Change for Bacterial Outer Membrane Proteins
The discovery of how a group of bacteria can rapidly adapt to changing growth conditions could have implications for future antibiotic development.
Thursday, June 18, 2015
Protein The Clue To Solving A Darwinian Mystery
Scientists at the University of York provided the key to solving the evolutionary puzzle surrounding that Charles Darwin called the ‘strangest animals ever discovered’.
Thursday, March 19, 2015
York Scientists To Map Haematological Cancer DNA
UK researchers have launched an ambitious project to analyse samples from over 20,000 blood cancer patients to identify how differences in their cancer cell’s DNA can influence the success of treatment.
Wednesday, February 11, 2015
Plant Variants Point the Way to Improved Biofuel Production
Manufacturing biofuels from food crop by-products such as straw could be made quicker and cheaper thanks to a new study led by scientists at the University of York.
Thursday, September 25, 2014
New Approach Aims to Silence Cancer ‘Survival Genes’
Scientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death.
Thursday, September 25, 2014
Embalming Study ‘Rewrites’ Key Chapter in Egyptian History
New evidence to suggest that the origins of mummification started in ancient Egypt 1,500 years earlier than previously thought.
Thursday, August 14, 2014
Significant Step Forward in Biofuels Quest
Researchers from the Department of Chemistry at York have discovered a family of enzymes that can degrade hard-to-digest biomass into its constituent sugars.
Monday, December 23, 2013
York Scientists Gain Prestigious Awards
A team of scientists working in the University of York’s chemistry department has received the prestigious ‘Rita and John Cornforth Award’ from the Royal Society of Chemistry.
Thursday, August 04, 2011
Gene discovery could help to boost crop yields
A discovery by scientists at the University of York of a vital feature of a plant's temperature sensing and growth mechanism could help to increase yields from crops.
Tuesday, August 17, 2010
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!